COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics

NEW YORK–(BUSINESS WIRE)–COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH) that will allow biopharmaceutical researchers to access the combined resources of COTA’s research-grade electronic health record (EHR) data from academic and community care centers and Guardant’s clinicogenomic […]
Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence

Findings to be Presented at the San Antonio Breast Cancer Symposium NEW YORK, Dec. 9, 2024 /PRNewswire/ — COTA Inc., a leader in real-world data (RWD) and analytics for oncology, PreciseDx, an innovator in AI-powered digital pathology focused on oncology diagnostics, and Baptist Health South Florida today announced new study results validating the artificial intelligence […]
Real-world data gets high marks for feasibility in lung cancer research: A cross-industry collaboration is advancing RWD

The real world is an unpredictable place. It can be messy and confusing, full of challenges and uncertainties that have to be overcome before we can move forward with confidence and clarity toward our goals. The same is true of the real-world data (RWD) generated by clinicians, health plans, medical devices, patients, and more. Before […]
Light the Night: Bringing hope to patients during Blood Cancer Awareness Month

September is Blood Cancer Awareness Month, a time to bring extra attention to the more than 1.6 million people living with leukemia, lymphoma, myeloma, and other hematological cancers. These cancers can strike people of all ages, including children and young adults. Blood cancers account for almost 10% of all new cancer diagnoses in the US […]
COTA and Panalgo Q&A

COTA Spokesperson: C.K. Wang, Chief Medical Officer Panalgo Spokesperson: Meg Richards, PhD, MPH, Executive Director of Scientific Strategy Abbreviated answers Q: What is the value of real-world data for accurate healthcare analytics – what can be learned from high-quality electronic health record data? Meg: Real-world data (RWD), particularly those derived from high-quality electronic health records […]
Panalgo Partners with COTA, Adding Oncology Data to Its Industry-Leading IHD Platform

Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings clarity to cancer care with a precise, patient-first approach based on real-world data (RWD). BOSTON, Sept. 9, 2024 /PRNewswire-PRWeb/ — Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that […]
The promise of clinicogenomic data for breakthrough cancer drug development

Life science companies have many different data types at their disposal to support research and development, from established literature and clinical trial evidence to a growing range of real-world data (RWD) assets that are opening up new opportunities every day. Among these novel datasets is clinicogenomic data: a mashup of longitudinal, deidentified clinical information with […]